Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Ion Beam Applications SA (OTCMKTS:IOBCF – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 86,740 shares of the company’s stock, valued at approximately $9,577,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of IOBCF. BlackRock Inc. acquired a new position in Ion Beam Applications in the 2nd quarter worth about $488,621,000. Deutsche Bank AG acquired a new stake in shares of Ion Beam Applications during the second quarter valued at about $10,140,000. Ieq Capital LLC acquired a new stake in shares of Ion Beam Applications during the second quarter valued at about $4,072,000. Old West Investment Management LLC bought a new stake in shares of Ion Beam Applications during the second quarter worth about $1,082,000. Finally, State of Wyoming bought a new stake in shares of Ion Beam Applications during the second quarter worth about $695,000. Institutional investors own 14.86% of the company’s stock.
Ion Beam Applications Trading Down 0.4%
OTCMKTS:IOBCF opened at $18.51 on Thursday. The firm’s 50 day simple moving average is $18.82 and its 200 day simple moving average is $17.86. Ion Beam Applications SA has a one year low of $11.45 and a one year high of $20.10.
Ion Beam Applications Profile
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.
See Also
- Five stocks we like better than Ion Beam Applications
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.
